INVESTOR RELATIONS/CONSULTING AGREEMENTConsulting Agreement • November 28th, 2007 • Sanguine Corp • In vitro & in vivo diagnostic substances • California
This Consulting Agreement ("Agreement"), made and entered into this 4th of April, 2007, by and between Sanguine Corp. (the "Company"), and LKB Partners, LLC. ("Consultant"),
OPTION AGREEMENTOption Agreement • November 28th, 2007 • Sanguine Corp • In vitro & in vivo diagnostic substances
THIS OPTION AGREEMENT (this “Agreement”) is entered into as of November 21st, 2007, by and between Thomas C. Drees an individual (the “Seller”), and Terra Silex Holdings LLC, a Pennsylvania LLC (the “Holder”), together with any successors and assigns.
MANAGEMENT CONSULTING AGREEMENTManagement Consulting Agreement • November 28th, 2007 • Sanguine Corp • In vitro & in vivo diagnostic substances • California
This Consulting Agreement (“Agreement”), made and entered into this 25th of September, 2007, by and between Sanguine Corp. (hereinafter also the “Company” and “SGNC” ), and Thomas C. Drees, Ph.D. (“Consultant”),
Stock Option AgreementStock Option Agreement • November 28th, 2007 • Sanguine Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT made as of this 21st day of November, 2007 by and between Thomas C. Drees, an individual of Pasadena, CA (the “Optionor”) and LKB Partners, LLC, of Exton, PA (the “Optionee”).
CONSULTING AND CONFIDENTIALITY AGREEMENTConsulting Agreement • November 28th, 2007 • Sanguine Corp • In vitro & in vivo diagnostic substances
THIS CONSULTING AGREEMENT (hereinafter the “Agreement”), made and entered into this 25th day of October, 2007, by and between KKS Venture Management Inc. and Alfonso Knoll (hereinafter “Consultants”), an independent contractor with a business address of 240 Main Street, Denver PA 17517, and Sanguine Corporation a Nevada corporation (hereinafter “the Company”), (hereinafter together referred to as “the Parties”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 28th, 2007 • Sanguine Corp • In vitro & in vivo diagnostic substances
This Stock Purchase Agreement (this “Agreement”) is made and entered into as of September__, 2007 by and among Sanguine Corporation a Nevada corporation (the “Company”), and Terra Silex Holdings LLC, a Pennsylvania LLC (the “Investor”).
MANAGEMENT CONSULTING AGREEMENTManagement Consulting Agreement • November 28th, 2007 • Sanguine Corp • In vitro & in vivo diagnostic substances • California
This Consulting Agreement (“Agreement”), made and entered into this 22 of August, 2007, by and between Sanguine Corp. (hereinafter also the “Company” and “SGNC”), and LKB Partners, LLC. (“Consultant”),
